newsfilter
← Latest News
GlobeNewswire·

MAIA Biotechnology Announces Pricing of $30 Million Underwritten Public Offering of Common Stock

Financing included participation by healthcare-dedicated investors alongsideexisting shareholders CHICAGO, IL, March 02, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a